Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Tampere University | OTHER |
| Kuopio University Hospital | OTHER |
| University of Eastern Finland | OTHER |
| University of Turku |
Not provided
Not provided
Not provided
Mammography is the most common method for breast imaging, and it provides information for model building and analysis. Radiomics applied to mammography has the potential to revolutionize clinical decision-making by providing valuable insights into risk assessment and disease detection. Despite this, the influence of imaging parameters and clinical and biological factors on radiological texture features remains poorly understood. There is a pressing need to overcome the obstacle of system-inherent effects on mammographic images to facilitate the translation of radiological texture features into routine clinical practice by enabling reliable and robust AI-based or AI-aided decision-making. Furthermore, understanding the relationship between imaging parameters, textural features, and clinical and biological information supports the clinical use of AI. The objective of this study is to evaluate AI methods for clinical practice and to study how it relates to clinical factors and biological features.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Participant diagnosed with breast cancer | Experimental | Participants diagnosed with breast cancer who will undergo a mastectomy operation |
|
| Participant not diagnosed with breast cancer | Experimental | Participants who will undergo a mastectomy operation for a non-breast cancer related clinical indication |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AI tool | Device | Both the arms will undergo the use of "AI tool" developed in the group. The tool will be trained to detect outcomes. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mammographic texture features | Aim: to evaluate how imaging parameters affect the mammographic texture features | Through study completion, an average of 5 year |
| Measure | Description | Time Frame |
|---|---|---|
| Biological features | Aim: To evaluate whether there is an interplay between mammographic texture feature parameters and pathological and biological features (e.g., breast cancer biomarkers) | through study completion, an average of 10 year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Otso Arponen, MD, PhD | Contact | +3583311611 | otso.arponen@tuni.fi |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
| OTHER |
| University of Oulu | OTHER |
Not provided
Not provided
Not provided
Not provided
| D017437 |
| Skin and Connective Tissue Diseases |